Eurofins Medigenomix And Orion Diagnostica Oy Enter Into A License Agreement On Orion Diagnostica Oy’s Proprietary SIBA® Technology
Eurofins Medigenomix to develop and market testing services utilizing SIBA® technology(PresseBox) (Ebersberg, )
"Our general focus is to translate innovative and new technologies into new applications of DNA based analysis. This will allow our Eurofins Genomics business line to generate the high service level we want to provide to our customers", said Bruno Poddevin, Senior Vice President Eurofins Genomics. "The SIBA technology and the associated expertise of Orion Diagnostica are an excellent fit for Eurofins. The cooperation will allow us to broaden Eurofins' portfolio with innovative analytical solutions particularly in the area of DNA based authenticity testing for food and related products", added Peter Persigehl, Managing Director of Eurofins Medigenomix.
"Orion Diagnostica's new SIBA technology allows a fast, robust, and reliable detection of nucleic acids from a variety of sources and for different identification needs enabling wide range of uses in different fields. We are delighted to enter into this agreement with Eurofins Medigenomix, a leader in the field of Genetic Analyses, and look forward to collaborating on projects such as authenticity testing for clients worldwide," said Jaakko Rissanen, President, Orion Diagnostica Oy.